Business Context and Reporting Period
Company: E. I. du Pont de Nemours and Company (DuPont)
Filing Type: Form 8-K (Current Report)
Reporting Period: Second Quarter ended June 30, 2004
Date of Report: July 27, 2004
DuPont reported consolidated financial results for the second quarter of 2004. The period was characterized by the completion of the sale of the Textiles & Interiors business (INVISTA) on April 30, 2004, and the execution of a major phase of a $900 million cost improvement program. The company operates five core growth platforms: Agriculture & Nutrition, Electronic & Communication Technologies, Performance Materials, Pharmaceuticals, and Safety & Protection.
Key Financial Metrics
| Metric | Q2 2004 | Q2 2003 | YTD 2004 | YTD 2003 |
|---|---|---|---|---|
| Consolidated Net Sales | $7.53 billion | $7.37 billion | $15.60 billion | $14.38 billion |
| Segment Sales | $8.19 billion | $8.24 billion | $17.13 billion | $16.02 billion |
| Net Income (GAAP) | $503 million | $675 million | $1.17 billion | $1.21 billion |
| Diluted EPS (GAAP) | $0.50 | $0.67 | $1.16 | $1.21 |
| Net Income Before Special Items | $805 million | $623 million | $1.76 billion | $1.23 billion |
| Diluted EPS Before Special Items | $0.80 | $0.62 | $1.76 | $1.23 |
| EBITDA (Non-GAAP) | $1.43 billion | $1.23 billion | $3.14 billion | $2.54 billion |
Liquidity and Cash Flow: The sale of INVISTA generated after-tax proceeds of $4.1 billion, including debt assumed by the buyer of approximately $270 million. The filing text does not provide a specific value for free cash flow or total cash on hand for the period.
Material Changes Versus Prior Period
- Revenue: Consolidated net sales increased 2% year-over-year to $7.53 billion. Excluding portfolio changes (primarily the INVISTA divestiture), segment sales increased 9%.
- Profitability: Reported net income decreased 25% to $503 million due to significant special items. However, earnings before special items increased 29% to $805 million, driven by higher sales volumes, selling prices, and improved Pharmaceuticals earnings.
- Special Items: The company recorded a net after-tax charge of $302 million ($0.30 per share) in Q2 2004, compared to a net benefit of $52 million ($0.05 per share) in Q2 2003. Key charges included:
- Restructuring costs: $433 million pretax (including $312 million for employee separations and $121 million for asset impairments).
- INVISTA divestiture charges: $183 million pretax.
- Litigation reserves: $45 million pretax (PFOA class action).
- Segment Performance: All five core segments delivered double-digit revenue growth. Electronic & Communication Technologies saw a 15% sales increase, and Performance Materials saw a 26% increase. The Textiles & Interiors segment sales dropped 54% as the business was sold in April.
Guidance, Outlook, and Risks
Updated Outlook: DuPont increased its full-year 2004 earnings per share outlook.
- Previous Outlook: $2.10 to $2.30 per share.
- Updated Outlook: $2.25 to $2.35 per share.
This outlook excludes first and second-quarter special items and assumes strong industrial production growth, oil and natural gas prices remaining at or slightly below current high levels, and a modest currency benefit.
Management Commentary: CEO Charles O. Holliday, Jr. highlighted that the five growth platforms delivered strong growth in revenue, earnings, and cash despite high energy and raw material prices. The company completed the sale of Textiles & Interiors and executed a major phase of its cost improvement program.
Risks and Contingencies:
- Litigation: The company established reserves for PFOA class action litigation in West Virginia ($45 million) and DuPont Dow Elastomers antitrust matters ($150 million YTD).
- Market Conditions: Risks include changes in laws, regulations, economic conditions, inflation, interest rates, foreign currency exchange rates, and competitive pressures.
- Raw Materials: High energy and raw material prices continue to impact costs.
Investor Verification Checklist
- Special Items Impact: Verify the sustainability of earnings by analyzing the $302 million after-tax special charge, specifically the $433 million restructuring and $183 million INVISTA divestiture costs.
- INVISTA Proceeds: Confirm the utilization of the $4.1 billion in after-tax proceeds from the INVISTA sale (e.g., debt reduction, dividends, or reinvestment).
- Litigation Exposure: Review the details of the PFOA class action and DuPont Dow Elastomers antitrust litigation to assess potential future liabilities beyond the current reserves.
- Non-GAAP Reconciliation: Review Schedule G to understand the reconciliation between GAAP net income and the "Earnings Before Special Items" metric used for guidance.
- Raw Material Costs: Monitor the impact of high energy and raw material prices on future margins, as noted in management commentary.